because of the non-selective nature of complement , extracorporeal therapies employing hydrophilic cellulosic based materials can result in significant complement activation and systemic exposure to large amounts of c5a which in turn may lead to a variety of pathological sequelae .
C0009528
complement activation
C1367710
c5a